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A B S T R A C T
Purpose: Epidemiologic studies have shown that the incidence of epilepsy is the highest in the elderly
population. Because the elderly constitutes the most rapidly growing population, epilepsy in this group
is an important health issue worldwide. To identify the characteristics of epilepsy in the elderly, we
reviewed our experience at a tertiary referral center in Japan.
Methods: We searched all electronic medical records of the past 6 years at the epilepsy clinic of the
hospital afﬁliated to our University-afﬁliated hospital. We deﬁned an elderly person as an individual
aged 65 years and above. All patients underwent history and physical examinations, 3 T magnetic
resonance imaging and/or computer tomography, and electroencephalogram (EEG). The diagnosis of
epilepsy, age of onset, etiology, and antiepileptic medication were recorded.
Results: We identiﬁed 70 patients who developed epilepsy after the age of 65 years. The mean age of
seizure onset was 73.1 years and 52.9% patients were males. Complex partial seizures (CPS) without
secondarily generalization (n = 33, 47.1%) were most frequent. The most frequent diagnosis was
temporal lobe epilepsy (n = 50, 71.4%). Etiological diagnosis was possible in nearly 50% patients,
including those with cerebrovascular disease. A clear cause of epilepsy was not found (i.e., non-lesional
epilepsy) in 52.8% patients. Interictal EEG revealed focal epileptiform discharges in 72.9% (n = 51)
patients. Of the 54 patients who were followed more than 1 year, 42 patients (77.8%) were on
antiepileptic monotherapy and 52 patients (96.3%) had been seizure-free for more than 1 year.
Conclusion: The most frequent diagnosis in our cohort of elderly persons with new-onset epilepsy was
temporal lobe epilepsy. Non-lesional temporal lobe epilepsy was not uncommon. Epileptogenecity was
relatively low in elderly patients and they responded well to antiepileptic medication.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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The elderly population, comprising individuals aged 65 years
and above, is the most rapidly growing in the world. Among the
populations of 192 countries worldwide, the Japanese population
is the most aged.1 In Japan, the population ratio of the elderly was
23.1% in 2010. Furthermore, the population in Japan is aging at an
unparalleled speed compared with that in other countries.
Epidemiologic studies have shown that the incidence of
epilepsy is signiﬁcantly higher in the elderly than in any other
age group.2–6 Epilepsy in the elderly has speciﬁc features, including
aspects of etiology, clinical manifestations, and treatment* Corresponding author at: Department of Neurology, University of Occupational
and Environmental Health School of Medicine, 1-1 Iseigaoka, Yahata-nishi-ku,
Kitakyushu 807-8555, Japan. Tel.: +81 093 691 7438; fax: +81 093 693 9842.
E-mail address: tnk-a@koto.kpu-m.ac.jp (A. Tanaka).
1059-1311/$ – see front matter  2013 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2013.06.005responses, which are different from epilepsy in younger individu-
als. Clinicians who treat epilepsy in the elderly should be aware of
these important characteristics.
To determine the characteristics of epilepsy in the elderly in
Japan, we reviewed our experience at a tertiary referral center. It is
important and informative to examine epilepsy in the elderly in
Japan because the country has the most rapidly aging population
worldwide.
2. Methods
2.1. Subjects
Patients were selected from epilepsy registries of the epilepsy
clinic in the hospital afﬁliated to University of Occupational and
Environmental Health School of Medicine in Kitakyushu city,
Fukuoka Prefecture, Japan. We searched all electronic medical
records at this epilepsy clinic to identify cases of new-onsetvier Ltd. All rights reserved.
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Fig. 1. Classiﬁcation of epilepsies and epileptic syndromes. TLE, temporal lobe
epilepsy; FLE, frontal lobe epilepsy; OLE, occipital lobe epilepsy; PLE, parietal lobe
epilepsy; GE, generalized epilepsy; Other*, status epilepticus or situation-related
seizure.
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Fig. 2. Etiology of epilepsy in the elderly. Cerebrovascular disease: cerebral
infarction or hemorrhage. Others**: febrile myoclonus or metabolic disorder.
A. Tanaka et al. / Seizure 22 (2013) 772–775 773epilepsy in the elderly. We deﬁned elderly persons as individuals
aged 65 years and above. Patient enrollment began on March 1,
2005 and ended on June 30, 2011.
2.2. Diagnosis
Epilepsy was diagnosed by a board-certiﬁed epileptologist on
the basis of clinical information, including history, physical ﬁnding,
scalp-recorded electroencephalogram (EEG), 3.0-T magnetic reso-
nance imaging (MRI)/computed tomography, single photon
emission tomography, and neuropsychological evaluation.
Patients with acute symptomatic seizure7 were excluded from
the study. We excluded three patients who died of cancer during
the follow-up period. Nine patients were examined only once and
were lost to follow-up. 3.0-T MRI was performed using routine
imaging and a protocol for revealing mesial temporal lobe
abnormality.8 All MRI studies of the brain were reviewed by
board-certiﬁed neuroradiologists. Routine EEG was recorded with
digital EEG using international 10-20 electrodes with additional
anterior temporal electrodes (T1 and T2 electrodes). EEG was
reviewed by a board-certiﬁed electroencephalographer.
2.3. Antiepileptic medication
A case record form was used to collect data of the included
subjects. The classiﬁcation of epilepsy and seizure, age of onset,
etiology, antiepileptic medication (AED), AED dose, and treatment
responses were recorded. Seizure and epilepsy as well as epilepsy
syndrome were classiﬁed according to the criteria of the
International League Against Epilepsy.9,10
3. Results
Seventy patients were enrolled in the study; the mean age of
the patients with new-onset epileptic seizure was 73.1  6.9 years
(mean  SD), and 52.9% patients were males. According to the seizure
classiﬁcation, complex partial seizures (CPS) without secondarily
generalization (n = 33, 47.1%) were most frequently diagnosed,
followed by partial seizures with secondarily generalized tonic–
clonic seizures (n = 28, 40.0%), generalized seizures (n = 5, 7.1%), and
simple partial seizures (SPS) (n = 4, 5.7%).
Epilepsy diagnosis included temporal lobe epilepsy (TLE)
(n = 50, 71.4%), frontal lobe epilepsy (n = 6, 8.6%), other localiza-
tion-related epilepsy (n = 2, 2.9%), generalized epilepsy (n = 5,
7.1%) and unclassiﬁed epilepsy (n = 4, 5.1%) (Fig. 1). All patients
with generalized epilepsy had myoclonic seizures.
An etiological diagnosis was possible in nearly 50% patients,
including those with cerebrovascular disease such as cerebral
infarction or hemorrhage (n = 11, 15.7%), followed by dementia
(n = 7, 10.0%), inﬂammatory disorders (n = 6, 8.6%), brain tumors
(n = 3, 4.3%), and other conditions (n = 6, 8.6%) (Fig. 2). A clear cause
of epilepsy was not found in 52.8% patients (n = 37), i.e., these
patients were classiﬁed as having non-lesional epilepsy.Total
70
Followed
60
Lost for follow-up
10
Fig. 3. Prognosis of seizures in the elderly. Of the 70 patients, 10 patients were lostInterictal EEG results were as follows: focal epileptiform
discharges (n = 51, 72.9%), focal or generalized slowing without
epileptiform discharges (n = 8, 11.4%), and normal (n = 11, 15.7%).
Among the 70 patients included in this study, 10 were treated at
the referring clinic and prognostic information was unavailable. Of
the 60 patients follow-up information were available, 54 patients
were followed more than 1 year. Of the 54 patients followed, 52
patients (96.3%) had been seizure-free more than 1 year, and twoFollowed more th an 1 
year
54
Seizure  free
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6
 for follow up. Of the 60 patients, 54 patients were followed more than 1 year.
Table 1
Number of antiepileptic medications per patient.
Medication No. of patients (%)
Monotherapy 42 (77.8)
Two AEDs 7 (13.0)
Three AEDs 2 (3.7)
No medication 3 (5.6)
Forty-two patients were on monotherapy, 7 were on duotherapy, 2 were on three
drugs, and 3 were not treated with anti-epileptic drugs.
Table 2
Frequency of antiepileptic drug use.
Antiepileptic drug N = 62 (%) Doses (mg)/day (median [IQR])
Carbamazepine 21 (33.9) 200 (100–200)
Valproate 8 (12.9) 400 (350–700)
Clobazam 6 (9.7) 5.0 (2.5–10)
Gabapentin 9 (14.5) 400 (400–600)
Levetiracetam 7 (11.3) 500 (250–500)
Phenytoin 7 (11.3) 200 (200–200)
Phenobarbital 2 (3.2) 60
Clonazepam 1 (1.6) 0.5
Topiramate 1 (1.6) 25
For the 54 patients, 62 anti-epileptic drugs were prescribed in this study.
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54 patients followed, 42 (77.8%) were on monotherapy and 9
(18.3%) were and polytherapy and 3 were on no medication. Seven
(13.0%) patients received two AEDs and 2 (3.7%) patients received
three AEDs (Table 1).
Table 2 lists the antiepileptic medications prescribed for the 54
patients who were followed at our institution. Carbamazepine was
the most commonly used drug, followed by valproate.
4. Discussion
In this study, CPS without secondarily generalization were the
most common type of seizure among the patients of new-onset
epilepsy in the elderly. Our ﬁndings are in accordance with previous
studies reporting that the most frequent (43–49%) type of seizures in
the elderly are CPS.2,11 CPS in the elderly are often misdiagnosed as
altered mental status, memory disorders, or episodes of confusion.
The lack of secondarily generalized tonic–clonic seizures makes
epileptic seizures more difﬁcult to recognize and classify, which may
often lead to difﬁculty in diagnosing epilepsy. Our results supported
the necessity to publicize the knowledge that CPS is the most
common manifestation of epilepsy in the elderly.
Previous studies have emphasized that generalized tonic–
clonic seizures are recognized by most observers as epilepsy;
however, such seizures are rare in elderly patients (26%) than in
younger ones (65%).12 In our study, partial seizures with
secondarily generalized tonic–clonic seizures were observed in
40% patients. The rate of convulsive seizure in epilepsy in the
elderly may be smaller than that in younger patients; however, we
found that a signiﬁcant number of elderly patients developed
convulsive seizures.
In this study, we found that TLE was the most common type of
epilepsy. Few studies have reported epilepsy syndrome in the
elderly. Because TLE is the most common epilepsy in adults, it may
be reasonable to propose that the elderly also suffer from seizures
arising in the temporal lobe. In our cohort, MRI revealed that
majority of TLE cases were non-lesional, which suggests that the
cause of epilepsy in these cases may be related to the aging process
or a degenerative process that could not be identiﬁed by brain
imaging. However, further studies are necessary to accurately
classify epilepsy in the elderly.
It has been reported that the most common cause of seizures in
the elderly is cerebrovascular disease (34.1–39.3%); other etiolo-
gies include trauma, degenerative diseases, congenital malforma-
tions, brain tumors, or encephalitis.12–14 Our study showed that
cerebrovascular disease was the most common (15.7%) cause
identiﬁed; however, non-lesional epilepsy was the most frequent
type and constituted more than 50% cases (52.9%). Our results
showed a higher rate of non-lesional epilepsy compared with
previous reports, in which 25–40% new epilepsy cases in patients
above 60 years of age had no obvious or unknown etiology.12–14
Our study was conducted at a tertiary referral center; therefore, it
may have been affected by signiﬁcant referral biases. Patients with
a known etiology are usually treated by local physicians; however,
those with an unknown etiology tend to be referred to our clinic.
Further epidemiological studies are necessary to determinewhether the incidence of non-lesional epilepsy in the elderly is
indeed increasing.
Most individuals with newly diagnosed epilepsy responded to
treatment with their ﬁrst AED. In fact, 77.8% (42 patients of 54
followed) of our population were seizure free on one medication. A
previous study showed that seizures in elderly patients respond
well to treatment and that AEDs effectively control seizures in
approximately 80–86% of the elderly population.15,16 Most AEDs
are effective for treating common seizures in the elderly.
Carbamazepine was the most commonly used AED. Accurate
classiﬁcation of seizures and syndromes is essential to ensure an
appropriate choice of AED. The elderly are more likely to
experience good outcomes compared with other age groups.17
The elderly patients reported here became seizure-free after
receiving a relatively low dose of medication, which is consistent
with the results of previous reports.
The frequency of interictal epileptiform activity (IEA) in the
elderly patients with epilepsy included in our study was 72.9%.
Individuals with focal spikes have a 78% risk of developing epileptic
seizures.18 IEA detection can conﬁrm the presence of a physiologi-
cally abnormal brain, solidifying the diagnosis of an epileptic vs. a
nonepileptic seizure. A previous study showed that IEA was present
in 26% patients with seizure onset after 60 years.19 The rate of IEA in
routine EEG studies must be recognized when considering the
diagnosis of an epileptic syndrome for episodic events occurring in
the elderly. Our results suggest the high sensitivity of routine EEG for
detecting IEA. Therefore, EEG should be performed when a diagnosis
of epilepsy is suspected in the elderly.
5. Conclusion
In our cohort of elderly persons with new-onset epilepsy, TLE
was most frequently diagnosed, followed by frontal lobe epilepsy.
Non-lesional TLE was not uncommon. Epileptogenecity was
relatively low in the elderly patients and responded well to
antiepileptic medication.
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